1-3 of 3
Authors: Daniel Schmolze
Save search
Sort by
Journal Article

Phase I Trial of Ipatasertib Plus Carboplatin, Carboplatin/Paclitaxel, or Capecitabine and Atezolizumab in Metastatic Triple-Negative Breast Cancer

PDF
Yuan Yuan and others
The Oncologist, Volume 28, Issue 7, July 2023, Pages e498–e507, https://doi.org/10.1093/oncolo/oyad026
Published: 06 April 2023
Journal Article

A Phase II Clinical Trial of Pembrolizumab and Enobosarm in Patients with Androgen Receptor‐Positive Metastatic Triple‐Negative Breast Cancer

PDF
Yuan Yuan and others
The Oncologist, Volume 26, Issue 2, February 2021, Pages 99–e217, https://doi.org/10.1002/onco.13583
Published: 24 November 2020
Journal Article

Phase II Trial of Neoadjuvant Carboplatin and Nab‐Paclitaxel in Patients with Triple‐Negative Breast Cancer

PDF
Yuan Yuan and others
The Oncologist, Volume 26, Issue 3, March 2021, Pages e382–e393, https://doi.org/10.1002/onco.13574
Published: 08 November 2020